日本発なのに米国企業へ“転生”続々、創薬スタートアップ 「100均問題」足かせ
MediaPortfolio Companies
日本発なのに米国企業へ“転生”続々、創薬スタートアップ 「100均問題」足かせ
September 18, 2025

Press Release
Portfolio Companies
Crystalys Therapeutics Advances Phase 3 Trials of Dotinurad for the Treatment of Gout with Dosing of First Patient
San Diego, October 21, 2025

Press Release
Portfolio Companies
AN Venture Partner’s New Portfolio Company, Crystalys Therapeutics Launches with $205M Series A Financing to Advance Next-Generation Gout Treatment
San Diego, September 30, 2025
